Objective

To analyze the measurement properties of the Brazilian-Portuguese version of the Tampa Scale for Kinesiophobia-11 in patients with fibromyalgia.

Methods

Assessment was made at three time points: baseline (n = 130) and 15 days (n = 54) and eight weeks after baseline (n = 51). Data collected at baseline were used to assess internal consistency, criterion and construct validity, and ceiling and floor effects. Data collected at baseline and 15 days after baseline were used to assess reliability and measurement error, and data collected before and after an eight-week exercise-based physical therapy intervention were used to assess interpretability of change scores.

Results

The Tampa Scale for Kinesiophobia-11 showed adequate internal consistency (Cronbach's alpha = 0.77; alpha if item deleted: 0.74–0.77), substantial reliability (intraclass correlation coefficient_2,1 = 0.85; 95% confidence interval: 0.75, 0.90), good measurement error (standard error of measurement: 2.65 points), and a minimal detectable change (90% confidence) of 6.16 points. For validity, the Tampa Scale for Kinesiophobia-11 showed a positive and good correlation with the original Tampa Scale for Kinesiophobia (r = 0.84, p < 0.01), positive and moderate correlation with the Pain Catastrophizing Scale (r = 0.55, p < 0.01), positive and weak correlation with the Numerical Pain Rating Scale (r = 0.25, p < 0.01), positive and moderate correlation with the Beck Depression Inventory (r = 0.39, p < 0.01), and no correlation with the Patient-Specific Functional Scale (r = 0.11, p = 0.23). Kinesiophobia, pain, function, catastrophizing, and depression statistically improved after the eight-week intervention (p < 0.01).

Conclusion

The Tampa Scale for Kinesiophobia-11 is consistent, reliable, and appropriate to assess fear of movement in patients with fibromyalgia in the clinical context. Responsiveness of the Tampa Scale for Kinesiophobia-11 should be tested in future studies.

中文翻译：

---

巴西-葡萄牙版坦帕量表对纤维肌痛患者 Kinesiophobia-11 的测量特性分析

客观的

分析巴西-葡萄牙版坦帕量表对纤维肌痛患者的 Kinesiophobia-11 的测量特性。

方法

在三个时间点进行评估：基线 ( n  =  130) 和 15 天 ( n  =  54) 以及基线后八周 ( n  =  51)。在基线收集的数据用于评估内部一致性、标准和结构有效性以及上限和下限效应。在基线和基线后 15 天收集的数据用于评估可靠性和测量误差，在基于运动的物理治疗干预八周之前和之后收集的数据用于评估变化评分的可解释性。

结果

坦帕运动恐惧症量表 11 显示出足够的内部一致性（克朗巴赫的 alpha  =  0.77；如果删除项目的 alpha：0.74–0.77），显着的可靠性（类内相关系数_2,1  =  0.85；95% 置信区间：0.75, 0.90），良好测量误差（测量标准误差：2.65 分），最小可检测变化（90% 置信度）为 6.16 分。就有效性而言，坦帕运动恐惧症量表与原始坦帕运动恐惧症量表 ( r  =  0.84, p  <  0.01) 呈正相关且良好相关，与疼痛灾难化量表呈正中相关 ( r  =  0.55, p  < 0.01），与数字疼痛评定量表呈正相关和弱相关（r  =  0.25，p  <  0.01），与贝克抑郁量表呈正中相关（r  =  0.39，p  <  0.01），与特定患者无相关性功能量表 ( r  =  0.11, p  =  0.23)。八周干预后，运动恐惧症、疼痛、功能、灾难化和抑郁症在统计学上有所改善 ( p  <  0.01)。

结论

坦帕运动恐惧症量表 11 一致、可靠且适用于评估临床背景下纤维肌痛患者的运动恐惧。坦帕量表对 Kinesiophobia-11 的反应性应在未来的研究中进行测试。